Suppr超能文献

精神分裂症患者自评和临床医生评定的疾病严重程度的决定因素。

Determinants of patient-rated and clinician-rated illness severity in schizophrenia.

机构信息

Schizophrenia Division, Centre for Addiction and Mental Health, 250 College St, Room 320, Toronto, Ontario, Canada M5T 1R8

出版信息

J Clin Psychiatry. 2015 Jul;76(7):924-30. doi: 10.4088/JCP.14m09128.

Abstract

OBJECTIVE

The contribution of specific symptoms on ratings of global illness severity in patients with schizophrenia is not well understood. The present study examined the clinical determinants of clinician and patient ratings of overall illness severity.

METHOD

This study included 1,010 patients with a DSM-IV diagnosis of schizophrenia who participated in the baseline visit of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study conducted between January 2001 and December 2004 and who had available symptom severity, side effect burden, cognition, and community functioning data. Both clinicians and patients completed the 7-point Clinical Global Impressions-Severity of Illness scale (CGI-S), the primary measure of interest in the present study. Symptoms were rated using the Positive and Negative Syndrome Scale and the Calgary Depression Scale for Schizophrenia, and functional status with the Quality of Life Scale. Neurocognition, insight, and medication-related side effects were also evaluated.

RESULTS

Clinicians rated illness severity significantly higher than patients (P < .001). There was moderate overlap between CGI-S ratings made by clinicians and patients, with almost one third of patients showing substantial (ie, greater than 1 point) discrepancies with clinician ratings. Clinician-rated CGI-S scores were most strongly associated with positive symptoms, with additional independent contributions made by negative, disorganized, and depressive symptoms, as well as functional outcome (all P values < .01). Patient-rated CGI-S scores, on the other hand, were most closely related to depressive symptoms, with additional independent contributions made by positive and anxiety symptoms, clinical insight, and neurocognition (all P values < .01). Depressive symptoms were the strongest predictor of patient-rated CGI-S scores even in patients with good clinical insight (P < .001).

CONCLUSIONS

Patient and clinician views of overall illness severity are not necessarily interchangeable and differ in their clinical correlates. Taking these differences into account may enhance patient engagement in care and improve outcomes.

TRIAL REGISTRATION

ClinicalTrials.gov identifier: NCT00014001.

摘要

目的

精神分裂症患者的特定症状对整体疾病严重程度评分的影响尚不清楚。本研究旨在探讨临床医生和患者对整体疾病严重程度评分的临床决定因素。

方法

本研究纳入了 1010 名符合 DSM-IV 精神分裂症诊断标准的患者,他们参加了 2001 年 1 月至 2004 年 12 月期间进行的临床抗精神病药物干预效果试验(CATIE)的基线访视,并且有可用的症状严重程度、副作用负担、认知和社区功能数据。临床医生和患者均完成了 7 分制临床总体印象严重程度量表(CGI-S)的评估,这是本研究的主要测量指标。使用阳性和阴性症状量表(PANSS)和 Calgary 精神分裂症抑郁量表(CADS)评估症状,使用生活质量量表(QLS)评估功能状态。还评估了神经认知、洞察力和与药物相关的副作用。

结果

临床医生对疾病严重程度的评估明显高于患者(P<0.001)。临床医生和患者的 CGI-S 评分之间存在中度重叠,近三分之一的患者与临床医生的评分存在明显差异(即大于 1 分)。临床医生评定的 CGI-S 评分与阳性症状相关性最强,负性症状、思维紊乱和抑郁症状以及功能结局也有独立的贡献(均 P 值<0.01)。另一方面,患者评定的 CGI-S 评分与抑郁症状最为密切相关,阳性症状、焦虑症状、临床洞察力和神经认知也有独立的贡献(均 P 值<0.01)。即使在具有良好临床洞察力的患者中,抑郁症状也是患者评定的 CGI-S 评分的最强预测因子(P<0.001)。

结论

患者和临床医生对整体疾病严重程度的看法不一定可以互换,并且在其临床相关性方面存在差异。考虑到这些差异可能会增强患者对治疗的参与度并改善结局。

试验注册

ClinicalTrials.gov 标识符:NCT00014001。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验